PL2925856T3 - Sposoby wytwarzania komórek RPE - Google Patents
Sposoby wytwarzania komórek RPEInfo
- Publication number
- PL2925856T3 PL2925856T3 PL13844534T PL13844534T PL2925856T3 PL 2925856 T3 PL2925856 T3 PL 2925856T3 PL 13844534 T PL13844534 T PL 13844534T PL 13844534 T PL13844534 T PL 13844534T PL 2925856 T3 PL2925856 T3 PL 2925856T3
- Authority
- PL
- Poland
- Prior art keywords
- methods
- rpe cells
- producing rpe
- producing
- cells
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0621—Eye cells, e.g. cornea, iris pigmented cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
- C12N5/0056—Xeno-free medium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
- C12N2500/92—Medium free of human- or animal-derived components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/98—Xeno-free medium and culture conditions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins
- C12N2533/52—Fibronectin; Laminin
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Ophthalmology & Optometry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Developmental Biology & Embryology (AREA)
- Virology (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261732764P | 2012-12-03 | 2012-12-03 | |
| US201261733314P | 2012-12-04 | 2012-12-04 | |
| EP13844534.1A EP2925856B1 (en) | 2012-12-03 | 2013-12-03 | Methods of producing rpe cells |
| PCT/IB2013/003160 WO2014087244A2 (en) | 2012-12-03 | 2013-12-03 | Methods of producing rpe cells |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2925856T3 true PL2925856T3 (pl) | 2018-07-31 |
Family
ID=50439420
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL13844534T PL2925856T3 (pl) | 2012-12-03 | 2013-12-03 | Sposoby wytwarzania komórek RPE |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US10889801B2 (pl) |
| EP (1) | EP2925856B1 (pl) |
| DK (1) | DK2925856T3 (pl) |
| ES (1) | ES2666668T3 (pl) |
| HR (1) | HRP20180418T1 (pl) |
| HU (1) | HUE038620T2 (pl) |
| PL (1) | PL2925856T3 (pl) |
| PT (1) | PT2925856T (pl) |
| RS (1) | RS57257B1 (pl) |
| SI (1) | SI2925856T1 (pl) |
| TR (1) | TR201807259T4 (pl) |
| WO (1) | WO2014087244A2 (pl) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL281453B (en) | 2009-11-17 | 2022-07-01 | Astellas Inst For Regenerative Medicine | Methods for preparing human rpe cells and pharmaceutical preparations of human rpe cells |
| TR201807259T4 (tr) * | 2012-12-03 | 2018-06-21 | Biolamina Ab | Rpe hücreleri üretim yöntemleri. |
| WO2015080297A1 (en) | 2013-11-27 | 2015-06-04 | Kyoto Prefectural Public University Corporation | Application of laminin to corneal endothelial cell culture |
| JP6770435B2 (ja) * | 2014-10-31 | 2020-10-14 | 京都府公立大学法人 | ラミニンによる網膜および神経の新規治療 |
| RU2718062C2 (ru) | 2014-10-31 | 2020-03-30 | Сэндзю Фармасьютикал Ко., Лтд. | Новое лечение роговицы с применением ламинина |
| CA2972575A1 (en) | 2014-12-30 | 2016-07-07 | Cell Cure Neurosciences Ltd. | Rpe cell populations and methods of generating same |
| US11066642B2 (en) | 2015-08-05 | 2021-07-20 | Cell Cure Neurosciences Ltd | Preparation of retinal pigment epithelium cells |
| JP6987769B2 (ja) | 2015-10-26 | 2022-01-05 | セル キュア ニューロサイエンシズ リミテッド | 網膜色素上皮細胞の調製法 |
| JP7067744B2 (ja) * | 2016-06-30 | 2022-05-16 | 株式会社ヘリオス | 移植用媒体 |
| WO2019078781A1 (en) | 2017-10-17 | 2019-04-25 | National University Of Singapore | SYSTEMS AND METHODS FOR PRODUCING PHOTORECEPTOR PROGENITORS |
| WO2019130061A2 (en) | 2017-12-29 | 2019-07-04 | Cell Cure Neurosciences Ltd. | Retinal pigment epithelium cell compositions |
| PT4234024T (pt) | 2018-06-20 | 2026-01-21 | Biolamina Ab | Métodos e composições para produzir células do epitélio do pigmento da retina |
| CN118871141A (zh) | 2022-03-16 | 2024-10-29 | 住友制药株式会社 | 移植用介质 |
| EP4659755A1 (en) | 2023-02-14 | 2025-12-10 | RACTHERA Co., Ltd. | Therapeutic drug for retinal pigment epithelium tears |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10829733B2 (en) | 2007-01-04 | 2020-11-10 | Biolamina Ab | Composition and method for enabling proliferation of pluripotent human stem cells |
| BR112013017629A2 (pt) * | 2010-12-17 | 2017-04-18 | Biolamina Ab | laminina-521 recombinante |
| US9850463B2 (en) | 2012-02-01 | 2017-12-26 | The Regents Of The University Of California | Methods of culturing retinal pigmented epithelium cells, including xeno-free production, RPE enrichment, and cryopreservation |
| TR201807259T4 (tr) * | 2012-12-03 | 2018-06-21 | Biolamina Ab | Rpe hücreleri üretim yöntemleri. |
-
2013
- 2013-12-03 TR TR2018/07259T patent/TR201807259T4/tr unknown
- 2013-12-03 EP EP13844534.1A patent/EP2925856B1/en active Active
- 2013-12-03 SI SI201331007T patent/SI2925856T1/en unknown
- 2013-12-03 PT PT138445341T patent/PT2925856T/pt unknown
- 2013-12-03 DK DK13844534.1T patent/DK2925856T3/en active
- 2013-12-03 ES ES13844534.1T patent/ES2666668T3/es active Active
- 2013-12-03 HR HRP20180418TT patent/HRP20180418T1/hr unknown
- 2013-12-03 US US14/646,059 patent/US10889801B2/en active Active
- 2013-12-03 PL PL13844534T patent/PL2925856T3/pl unknown
- 2013-12-03 RS RS20180606A patent/RS57257B1/sr unknown
- 2013-12-03 HU HUE13844534A patent/HUE038620T2/hu unknown
- 2013-12-03 WO PCT/IB2013/003160 patent/WO2014087244A2/en not_active Ceased
-
2020
- 2020-12-30 US US17/138,327 patent/US11767509B2/en active Active
-
2023
- 2023-08-22 US US18/453,712 patent/US12195757B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US11767509B2 (en) | 2023-09-26 |
| RS57257B1 (sr) | 2018-08-31 |
| US20150299653A1 (en) | 2015-10-22 |
| US20210139848A1 (en) | 2021-05-13 |
| US20240228955A9 (en) | 2024-07-11 |
| US12195757B2 (en) | 2025-01-14 |
| SI2925856T1 (en) | 2018-06-29 |
| PT2925856T (pt) | 2018-06-15 |
| HRP20180418T1 (hr) | 2018-04-20 |
| EP2925856A2 (en) | 2015-10-07 |
| US20240132838A1 (en) | 2024-04-25 |
| HUE038620T2 (hu) | 2018-10-29 |
| US10889801B2 (en) | 2021-01-12 |
| TR201807259T4 (tr) | 2018-06-21 |
| WO2014087244A2 (en) | 2014-06-12 |
| WO2014087244A3 (en) | 2014-08-21 |
| EP2925856B1 (en) | 2018-03-07 |
| DK2925856T3 (en) | 2018-05-07 |
| ES2666668T3 (es) | 2018-05-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUE038620T2 (hu) | Eljárások RPE sejtek elõállítására | |
| EP2892577A4 (en) | METHOD OF TISSUE GENERATION | |
| ZA201502433B (en) | Methods of host cell modification | |
| SG11201404677TA (en) | Process of expanding t cells | |
| SG11201501729TA (en) | Three-dimensional cell culturing | |
| EP2855745A4 (en) | METHODS RELATING TO ADALIMUM AB | |
| EP2971014A4 (en) | CELL CULTURE METHODS | |
| EP2971040A4 (en) | CELL CULTURE METHODS | |
| SI2897465T1 (sl) | Postopek izdelave stabilnega, s pršenjem sušenega sestavka | |
| EP2665696A4 (en) | PROCESS FOR THE PREPARATION OF 2,3,3,3-TETRAFLUOR-2-PROPENE | |
| SG11201405573WA (en) | Production of graphene | |
| EP2815546A4 (en) | CONSTRUCTION OF A LARGE SCALE DVPN | |
| PL2836460T3 (pl) | Sposób wytwarzania grafenu | |
| ZA201406494B (en) | Methods of producing sulfilimine compounds | |
| ZA201502519B (en) | Production of particles | |
| GB201200458D0 (en) | Methods of preparing cells and compositions | |
| PL2870188T3 (pl) | Wytwarzanie tworzyw piankowych o ulepszonych właściwościach | |
| EP2856159A4 (en) | METHODS RELATING TO DENOSUMAB | |
| PL2931937T3 (pl) | Sposób wytwarzania układów nanocząstek metali | |
| AP3754A (en) | Method of culturing algae | |
| HUE041814T2 (hu) | Eljárás izoidid elõállítására | |
| GB2501101B (en) | Method of culturing algae | |
| GB201220155D0 (en) | Method of manufacture | |
| IL237862A0 (en) | Methods to reduce the formation of scale | |
| ZA201405321B (en) | Methods of ganglioside production |